These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 31570769
1. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma. Brich S, Bozzi F, Perrone F, Tamborini E, Cabras AD, Deraco M, Stacchiotti S, Dagrada GP, Pilotti S. Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769 [Abstract] [Full Text] [Related]
2. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma. Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N, Seethala RR, Dacic S. Mod Pathol; 2016 Jan; 29(1):14-24. PubMed ID: 26493618 [Abstract] [Full Text] [Related]
3. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma. Kinoshita Y, Hamasaki M, Yoshimura M, Matsumoto S, Iwasaki A, Nabeshima K. Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129 [Abstract] [Full Text] [Related]
4. Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models. Kukuyan AM, Sementino E, Kadariya Y, Menges CW, Cheung M, Tan Y, Cai KQ, Slifker MJ, Peri S, Klein-Szanto AJ, Rauscher FJ, Testa JR. Cancer Res; 2019 Aug 15; 79(16):4113-4123. PubMed ID: 31151962 [Abstract] [Full Text] [Related]
5. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology. Aydogdu G, Özekinci S. Eur Rev Med Pharmacol Sci; 2023 Oct 15; 27(20):10001-10007. PubMed ID: 37916370 [Abstract] [Full Text] [Related]
11. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature. Hassan A, Prabhakaran S, Pulford E, Hocking AJ, Godbolt D, Ziad F, Pandita A, Wessels A, Hussey M, Russell PA, Klebe S. Pathology; 2024 Aug 15; 56(5):662-670. PubMed ID: 38789301 [Abstract] [Full Text] [Related]
15. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. Hwang HC, Sheffield BS, Rodriguez S, Thompson K, Tse CH, Gown AM, Churg A. Am J Surg Pathol; 2016 Jan 15; 40(1):120-6. PubMed ID: 26448191 [Abstract] [Full Text] [Related]
16. Investigation of MTAP and BAP1 staining loss and P16/CDKN2A deletion in pleural cytology specimens and its role in the diagnosis of mesothelioma. Şeker NS, Tekin E, Ak G, Metintaş M, Metintaş S, Dündar E. Diagn Cytopathol; 2024 Apr 15; 52(4):211-216. PubMed ID: 38243885 [Abstract] [Full Text] [Related]
20. Update of pathological diagnosis of pleural mesothelioma using genomic-based morphological techniques, for both histological and cytological investigations. Nabeshima K, Hamasaki M, Kinoshita Y, Matsumoto S, Sa-Ngiamwibool P. Pathol Int; 2022 Aug 15; 72(8):389-401. PubMed ID: 35596704 [Abstract] [Full Text] [Related] Page: [Next] [New Search]